These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics. Phan JH, Quo CF, Wang MD. Prog Brain Res; 2006; 158():83-108. PubMed ID: 17027692 [Abstract] [Full Text] [Related]
3. Uncharacterized/hypothetical proteins in biomedical 'omics' experiments: is novelty being swept under the carpet? Pawłowski K. Brief Funct Genomic Proteomic; 2008 Jul; 7(4):283-90. PubMed ID: 18641417 [Abstract] [Full Text] [Related]
4. Infectious salmon anaemia virus (ISAV) isolates induce distinct gene expression responses in the Atlantic salmon (Salmo salar) macrophage/dendritic-like cell line TO, assessed using genomic techniques. Workenhe ST, Hori TS, Rise ML, Kibenge MJ, Kibenge FS. Mol Immunol; 2009 Sep; 46(15):2955-74. PubMed ID: 19616850 [Abstract] [Full Text] [Related]
5. FatiGO +: a functional profiling tool for genomic data. Integration of functional annotation, regulatory motifs and interaction data with microarray experiments. Al-Shahrour F, Minguez P, Tárraga J, Medina I, Alloza E, Montaner D, Dopazo J. Nucleic Acids Res; 2007 Jul; 35(Web Server issue):W91-6. PubMed ID: 17478504 [Abstract] [Full Text] [Related]
6. Functional Genomics meets neurodegenerative disorders Part I: transcriptomic and proteomic technology. David DC, Hoerndli F, Götz J. Prog Neurobiol; 2005 Jun; 76(3):153-68. PubMed ID: 16168556 [Abstract] [Full Text] [Related]
9. Where are we in genomics? Hocquette JF. J Physiol Pharmacol; 2005 Jun; 56 Suppl 3():37-70. PubMed ID: 16077195 [Abstract] [Full Text] [Related]
10. Transcriptomics, proteomics and interactomics: unique approaches to track the insights of bioremediation. Singh OV, Nagaraj NS. Brief Funct Genomic Proteomic; 2006 Feb; 4(4):355-62. PubMed ID: 17202126 [Abstract] [Full Text] [Related]
11. The use of gene array technology and proteomics in the search of new targets of diseases for therapeutics. Ferrer-Alcón M, Arteta D, Guerrero MJ, Fernandez-Orth D, Simón L, Martinez A. Toxicol Lett; 2009 Apr 10; 186(1):45-51. PubMed ID: 19022361 [Abstract] [Full Text] [Related]
13. Platelet genomics and proteomics in human health and disease. Macaulay IC, Carr P, Gusnanto A, Ouwehand WH, Fitzgerald D, Watkins NA. J Clin Invest; 2005 Dec 10; 115(12):3370-7. PubMed ID: 16322782 [Abstract] [Full Text] [Related]
14. Genetics, genomics and proteomics in atherosclerosis research. Tuomisto TT, Binder BR, Ylä-Herttuala S. Ann Med; 2005 Dec 10; 37(5):323-32. PubMed ID: 16179268 [Abstract] [Full Text] [Related]
15. Genomics of hepatitis B and C infections: diagnostic and therapeutic applications of microarray profiling. Berzsenyi MD, Roberts SK, Beard MR. Antivir Ther; 2006 Dec 10; 11(5):541-52. PubMed ID: 16964821 [Abstract] [Full Text] [Related]
19. Bioinformatics databases and tools in virology research: an overview. Yan Q. In Silico Biol; 2008 Oct 15; 8(2):71-85. PubMed ID: 18928197 [Abstract] [Full Text] [Related]
20. Impact of replicate types on proteomic expression analysis. Karp NA, Spencer M, Lindsay H, O'Dell K, Lilley KS. J Proteome Res; 2005 Oct 15; 4(5):1867-71. PubMed ID: 16212444 [Abstract] [Full Text] [Related] Page: [Next] [New Search]